Management of Recurrent Small Bowel Obstruction

Initial Management Approach

NPO status with nasogastric tube placement for gastric decompression to relieve vomiting and reduce bowel distension in patients with recurrent small bowel obstruction is recommended by the European Society of Gastrointestinal Endoscopy 1, 2
Bowel rest with nasogastric decompression is a key component of conservative management for partial obstruction, as suggested by the American Gastroenterological Association 1, 2, 4

Hyoscine butylbromide (Buscopan) intramuscularly is preferred for colicky abdominal pain in patients with recurrent small bowel obstruction, as recommended by the European Society of Gastrointestinal Endoscopy 6, 4
Ondansetron (5-HT3 antagonist) is first-line for antiemetic therapy in patients with recurrent small bowel obstruction, according to the National Institute for Health and Care Excellence 6, 4
Rifaximin is first-choice antibiotic for bacterial overgrowth causing diarrhea in patients with recurrent small bowel obstruction, as suggested by the American College of Gastroenterology 4

Metoclopramide should not be used long-term due to risk of irreversible tardive dyskinesia and extrapyramidal effects, as warned by the American Gastroenterological Association 5
Prokinetics should not be used in patients with prior bowel anastomosis, as recommended by the European Society of Gastrointestinal Endoscopy 5
Surgery should be avoided when possible in patients with chronic dysmotility, as suggested by the American Society of Colon and Rectal Surgeons 7, 8

Oral supplements and dietary adjustments should be tried first in patients with recurrent small bowel obstruction who become malnourished, as recommended by the American Society for Parenteral and Enteral Nutrition 2
Parenteral nutrition should only be used if enteral routes fail and significant malnutrition develops, according to the European Society for Clinical Nutrition and Metabolism 2, 7